Dotto Gian-paolo
Faculty of Biology and Medicine
Department of Biochemistry
University of Lausanne
Switzerland
Biography
Gian-Paolo Dotto. Dr. Dotto received his MD from the University of Turin, Italy, in 1979, and his PhD in Genetics from the Rockefeller University, New York, in 1983. After postdoctoral training with Robert A. Weinberg at the Whitehead Institute/MIT in Cambridge, Mass., in 1987 Dr. Dotto joined Yale University, New Haven, Connecticut, as assistant professor of Pathology. In 1992 he was promoted to the rank of associate professor and soon after moved to Harvard Medical School, as associate professor of Dermatology in the newly established Cutaneous Biology Research Center. In 2000 he was promoted to the rank of Professor at Harvard Medical School and Biologist at Massachusetts General Hospital. In 2002 he accepted a position of Professor in the Department of Biochemistry at the University of Lausanne, while retaining his position of Biologist at Massachusetts General Hospital. He has been elected to the European Molecular Biology Organization (2011), the Academia Europaea (2012) and the Leopoldina German National Academy of Sciences (2014). He is the recipient of a number of awards, including the American Skin Association Achievement Award (2012), an ERC Advanced investigator grant award (2013) and a Jurg Tschopp Award for Excellence in Biological Sciences science (2015).
Research Interest
Laboratory of squamous / skin cancer prevention Cancers do not arise solely from a single deregulated group of cells but rather as a combined result of various alterations in organ and tissue homeostasis. In fact, many genetic changes found in invasive and metastatic tumors are also found in apparently normal tissues and, for reasons that are not yet understood, only a minor fraction of pre-malignant lesions progress to malignancy.
Publications
-
Dziunycz PJ, Neu J, Lefort K, Djerbi N, Freiberger SN, et al., (2017). CYFIP1 is directly controlled by NOTCH1 and down-regulated in cutaneous squamous cell carcinoma. PloS one. 2017 Apr 14;12(4):e0173000.
-
Kim DE, Procopio MG, Ghosh S, Jo SH, Goruppi S, et al., (2017). Convergent roles of ATF3 and CSL in chromatin control of cancer-associated fibroblast activation. Journal of Experimental Medicine. 2017 Jul 6:jem-20170724.
-
Özdemir BC, Dotto GP. (2017). Racial Differences in Cancer Susceptibility and Survival: More Than the Color of the Skin?. Trends in Cancer. 2017 Mar 6.